A growing number of patients with cancer have benefited from drugs that help the immune system fight cancer, such as immune checkpoint inhibitors. But most patients with cancers do not respond to these treatments. To try to develop more effective immunotherapies, two groups of researchers, working independently, have developed a type of drug that simultaneously targets two